Submission ID Name Sort Ascending Format Submitter Submitted Modified Certification
DDMODEL00000237 Zurlinden_2016_Population_PBPK_model_for_acetaminophen Original code Nan-Hung Hsieh 2017/03/27 2017/03/29 uncertified model
DDMODEL00000233 Zierhut_2008_Population PKPD model for Fc-osteoprotegerin in healthy postmenopausal women PharmML 0.8.x Kyle Baron 2016/11/18 2018/07/13 uncertified model
DDMODEL00000076 Yan_2011_EPO_biosimilar_PKPD Original code Celine Sarr 2015/12/09 2016/05/20 uncertified model
DDMODEL00000261 Wilbaux_2015_KPD_CTC.count_PSA Original code Melanie Wilbaux 2017/10/22 2017/10/22 uncertified model
DDMODEL00000063 Weight-HbA1c-Insulin-Glucose model Original code Steve Choy 2015/12/01 2015/12/11 uncertified model
DDMODEL00000093 WählbyHamrénJohansson_2015_CardiacSafety_TQT Original code Amy Cheung 2015/12/10 2015/12/11 uncertified model
DDMODEL00000091 Van Cauter C-peptide model PharmML Roberto Bizzotto 2015/12/10 2016/05/18 uncertified model
DDMODEL00000066 Ueckert 2016 ADAS-cog IRT model Original code Sebastian Ueckert 2015/12/01 2016/10/17 uncertified model
DDMODEL00000217 Tumour size dynamics model for ovarian cancer patients Original code Ivelina Gueorguieva 2016/10/07 2016/10/11 uncertified model
DDMODEL00000198 Tumor growth inhibition model for Sunitinib Treatment in GIST Original code Sreenath M Krishnan 2016/06/03 2016/06/03 uncertified model
DDMODEL00000065 TTE Paediatric Ciclosporin Model Original code Gopichand Gottipati 2015/12/01 2015/12/15 uncertified model
DDMODEL00000134 Tsukamoto 2001 PBPK/PD Model for Capecitabine Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000060 Troconiz_2009_epilepsy_NegativeBinomial Original code Elodie Plan 2015/12/01 2015/12/14 uncertified model
DDMODEL00000103 Trefz_2015_metabolism_Kuvan_TurnoverKPD PharmML Nadia Terranova 2015/12/11 2016/07/18 uncertified model
DDMODEL00000311 Translational PKPD of isoniazid from zebrafish to humans Original code Rob Christiaan van Wijk 2019/10/15 2020/09/04 uncertified model
DDMODEL00000268 Translational PKPD model on prolactin response following dopamine inhibition- human prediction and validation Original code Liesbeth de Lange 2017/12/13 2017/12/17 uncertified model
DDMODEL00000302 Time_to_event_Peripheral_Neuropathy_2019 Original code Matts Kågedal 2019/09/25 2019/09/25 uncertified model
DDMODEL00000243 Time to event modelling of competing risks Original code Joachim Grevel 2017/07/12 2017/07/19 uncertified model
DDMODEL00000104 Time to conversion of acute A-fib after intravenous digoxin Original code Shijun Wang 2015/12/11 2016/06/03 uncertified model
DDMODEL00000240 The Multistate Tuberculosis Pharmacometric model Original code Oskar Clewe 2017/05/10 2017/05/10 uncertified model
DDMODEL00000259 The MTP-GPDI model for pre-clinical exposure response and PD interaction identification Original code Oskar Clewe 2017/10/18 2017/11/15 uncertified model
DDMODEL00000067 The Betacell dynamics, Insulin and Glucose (BIG) Model Original code Eric Strömberg 2015/12/01 2015/12/10 uncertified model
DDMODEL00000274 Terranova_2017_oncology_TGI PharmML 0.8.x Elena Maria Tosca 2017/12/21 2017/12/22 uncertified model
DDMODEL00000096 Terranova_2013_oncology_TGI_combo PharmML 0.8.x Paolo Magni 2015/12/10 2016/10/10 uncertified model
DDMODEL00000212 TerHeine_2014_PK_Tamoxifen_ActiveMetabolite_CYP2D6 PharmML Lena Klopp-Schulze 2016/08/26 2016/08/30 uncertified model
DDMODEL00000049 TDM1_Antibody_Drug_Conjugate_PK_Model Original code Brendan Bender 2015/11/30 2015/12/17 uncertified model
DDMODEL00000137 Tate 2016 Metastatic Breast Cancer Tumour Growth Model for Paclitaxel/Gemcitabine Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000136 Tate 2016 Metastatic Breast Cancer Tumour Growth Model for Docetaxel Combinations Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000135 Tate 2016 Metastatic Breast Cancer Overall Survival Model Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000006 Simeoni_2004_oncology_TGI PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/05 certified model
DDMODEL00000195 Sibrotuzumab_PK_Carcinoma PharmML Niklas Hartung 2016/05/31 2016/07/15 uncertified model
DDMODEL00000043 Semiphysiological artemisinin PK in healthy subjects Original code Gunnar Yngman 2015/11/30 2016/06/03 uncertified model
DDMODEL00000221 Schindler_2016_SLD_SUV_OS_GIST Original code Emilie Schindler 2016/10/11 2016/10/12 uncertified model
DDMODEL00000069 Savic_transit_abs_glibenclamide_pk_original Original code Gustaf Wellhagen 2015/12/03 2016/10/14 uncertified model
DDMODEL00000122 Samtani_2010_Hb1Ac_prediction PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/10 uncertified model
DDMODEL00000262 Sahota_2015_CPHPC_TMDD_model Original code Alienor Berges 2017/10/25 2017/10/25 uncertified model
DDMODEL00000115 Russu_2009_dose_escalation_power PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000113 Russu_2009_dose_escalation_loglog PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000114 Russu_2009_dose_escalation_Emax PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000008 Rocchetti_2013_oncology_TGI_combo PharmML 0.8.x Paolo Magni 2014/09/26 2016/10/10 uncertified model
DDMODEL00000050 Rifampicin PKPD model in a tuberculosis mouse using Multistate Tuberculosis Pharmacometric Model Original code Chunli Chen 2015/11/30 2015/12/11 uncertified model
DDMODEL00000128 Ribba_2012_PCV PharmML Christian Laveille 2015/12/15 2015/12/16 uncertified model
DDMODEL00000061 Population PK of gentamicin in cancer patients with time-varying covariates Original code Kajsa Harling 2015/12/01 2016/05/26 uncertified model
DDMODEL00000070 Population PK of edoxaban and main metabolite in renal impairment Original code Siv Jonsson 2015/12/03 2016/10/06 uncertified model
DDMODEL00000238 Population PK model for gentamicin Original code Eva Germovsek 2017/03/28 2017/03/28 uncertified model
DDMODEL00000307 Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers Original code Joel Tarning 2019/10/03 2019/10/03 uncertified model
DDMODEL00000297 Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women Original code Joel Tarning 2019/02/05 2019/02/15 uncertified model
DDMODEL00000308 Population pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs in healthy volunteers Original code Joel Tarning 2019/10/03 2019/10/03 uncertified model
DDMODEL00000306 Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis Original code Richard Hoglund 2019/10/03 2019/10/03 uncertified model
DDMODEL00000309 Population pharmacokinetic properties of lumefantrine in malnourished children Original code Joel Tarning 2019/10/03 2019/10/03 uncertified model
Showing 1 to 50 of 151 models
First Previous 1 2 3 4 Next Last